SYON CAPITAL LLC

Position in GILD — Gilead Sciences, Inc.

CIK 1999353 SAN FRANCISCO, CA

Position in GILD

as of Mar 31, 2026 · filed May 13, 2026 Compact

Position Value

$2,891,230

+$279,692 QoQ

Shares Held

20,745

-2.5% QoQ

Ownership

0.002%

of shares outstanding

% of Portfolio

0.23%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Sep 2023

11 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

SYON CAPITAL LLC holds $41,641,759 across 15 Drug Manufacturers - General names. GILD ranks #6 (6.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	12,819	$11,790,531
2	JNJ	Johnson & Johnson	29,338	$7,171,380
3	ABBV	AbbVie Inc.	25,838	$5,619,506
4	MRK	Merck & Co., Inc.	25,670	$3,087,844
5	AMGN	Amgen Inc	8,271	$2,910,151
6	GILD	Gilead Sciences, Inc. This page	20,745	$2,891,230
7	AZN	Astrazeneca PLC	11,958	$2,358,356
8	GSK	GSK plc	29,471	$1,626,504

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$2,891,230	20,745	-2.5%	Shares	Sole	2026-05-13
2025-12-31	$2,611,538	21,277	+5.0%	Shares	Sole	2026-02-11
2025-09-30	$2,249,859	20,269	+3.7%	Shares	Sole	2025-11-07
2025-06-30	$2,166,399	19,540	+4.8%	Shares	Sole	2025-08-14
2025-03-31	$2,088,275	18,637	+3.1%	Shares	Sole	2025-05-15
2024-12-31	$1,669,957	18,079	+25.5%	Shares	Sole	2025-02-14
2024-09-30	$1,207,379	14,401	-0.3%	Shares	Sole	2024-11-13
2024-06-30	$991,483	14,451	+4.4%	Shares	Sole	2024-08-13
2024-03-31	$1,014,146	13,845	+6.7%	Shares	Sole	2024-05-14
2023-12-31	$1,051,104	12,975	+4.3%	Shares	Sole	2024-02-26
2023-09-30	$932,703	12,446	—	Shares	Sole	2023-11-03
No filing history on record for this holder in this stock.